Belite Bio, Inc (BLTE) forecast

Belite Bio, Inc (BLTE) forecast: price $150.18, trailing P/E -55.50, forward P/E 79.04. How to read the street's path.

$150.18Price
$6.05BMarket cap
-55.50P/E ?
79.04Forward P/E ?
0.00%Dividend yield ?

The live BLTE price is $150.18. Trailing P/E is -55.50 and forward P/E is 79.04. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the BLTE forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full BLTE quote · Dividends · Price prediction · Academy

Questions

What is BLTE's forward P/E?

The latest forward P/E on Stocklytics is 79.04, against a trailing P/E of -55.50 and a price of $150.18.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.